Melanoma is a subtype of skin cancer, partly driven by the MAPK signaling pathway through RAS-RAF-MEK-ERK signaling, which concludes in the activation of ERK, and regulates p-STAT, MITF-M, c-MYC, and other transcription factors, resulting in alteration of cell proliferation and survival. This evidence concerns the gene MAP2K7 and skin cancer.